Longitudinal assessment reveals severe pulmonary perfusion defects in patients with long COVID, suggesting lasting impacts of SARS-CoV-2 infection.
Pulmonary perfusion impairment persists up to 12 months following SARS-CoV-2 infection. Severe perfusion defects during acute phase are a risk factor for the development of long COVID.
No takes yet. Share an insight, caveat, or question.
Ouyang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: